La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

PhiChem Salute del bilancio

Salute finanziaria criteri di controllo 5/6

PhiChem ha un patrimonio netto totale di CN¥4.0B e un debito totale di CN¥1.8B, che porta il suo rapporto debito/patrimonio netto a 44.2%. Le sue attività totali e le sue passività totali sono rispettivamente CN¥6.5B e CN¥2.5B. L'EBIT di PhiChem è CN¥275.8M rendendo il suo rapporto di copertura degli interessi 30.3. Ha liquidità e investimenti a breve termine pari a CN¥1.3B.

Informazioni chiave

44.2%

Rapporto debito/patrimonio netto

CN¥1.77b

Debito

Indice di copertura degli interessi	30.3x
Contanti	CN¥1.31b
Patrimonio netto	CN¥4.01b
Totale passività	CN¥2.49b
Totale attività	CN¥6.50b

Aggiornamenti recenti sulla salute finanziaria

Is PhiChem (SZSE:300398) Using Too Much Debt?

May 25

Recent updates

PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%

Apr 18

PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The Company

Mar 04

Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)

Feb 26

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( CN¥3.3B ) di 300398 superano le sue passività a breve termine ( CN¥1.6B ).

Passività a lungo termine: Le attività a breve termine di 300398 ( CN¥3.3B ) superano le sue passività a lungo termine ( CN¥929.7M ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 11.6% ) di 300398 è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di 300398 è aumentato da 34.2% a 44.2% negli ultimi 5 anni.

Copertura del debito: Il debito di 300398 è ben coperto dal flusso di cassa operativo ( 28.6% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di 300398 sono ben coperti dall'EBIT ( 30.3 x copertura).

PhiChem Salute del bilancio

Salute finanziaria criteri di controllo 5/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Is PhiChem (SZSE:300398) Using Too Much Debt?

Recent updates

PhiChem Corporation's (SZSE:300398) Price In Tune With Earnings

PhiChem (SZSE:300398) Could Be Struggling To Allocate Capital

PhiChem Corporation Announces Final Dividend on A Shares for the Year 2023, Payable on July 16, 2024

PhiChem Corporation to Report First Half, 2024 Results on Aug 30, 2024

Investor sentiment deteriorates as stock falls 15%

New minor risk - Share price stability

Investor sentiment improves as stock rises 18%

Is PhiChem (SZSE:300398) Using Too Much Debt?

New minor risk - Earnings quality

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.14 in 1Q 2023)

PhiChem Corporation, Annual General Meeting, May 21, 2024

PhiChem Corporation (SZSE:300398) Might Not Be As Mispriced As It Looks After Plunging 26%

Investor sentiment deteriorates as stock falls 16%

PhiChem Corporation to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 15%

Investor sentiment improves as stock rises 18%

PhiChem Corporation (SZSE:300398) Stock Rockets 29% But Many Are Still Ignoring The Company

Returns On Capital Signal Tricky Times Ahead For PhiChem (SZSE:300398)

Investor sentiment deteriorates as stock falls 16%

PhiChem Corporation to Report Fiscal Year 2023 Results on Mar 30, 2024

Price target decreased by 10.0% to CN¥18.85

Investor sentiment improves as stock rises 18%

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.069 (vs CN¥0.13 in 3Q 2022)

Price target decreased by 12% to CN¥20.94

Second quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 2Q 2022)

New minor risk - Dividend sustainability

High number of new directors

PhiChem Corporation Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 02 June 2023

First quarter 2023 earnings released: EPS: CN¥0.14 (vs CN¥0.27 in 1Q 2022)

Price target decreased to CN¥19.50

Insufficient new directors

Consensus EPS estimates fall by 18%

Third quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 2Q 2021)

PhiChem Corporation Announces Cash Dividend, Payable on 16 June 2022

PhiChem Corporation (SZSE:300398) announces an Equity Buyback for CNY 100 million worth of its shares.

Insufficient new directors

PhiChem Corporation Approves Final Cash Dividend for the Year 2021

Consensus EPS estimates increase by 20%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

PhiChem Corporation, Annual General Meeting, Apr 20, 2022

Insufficient new directors

PhiChem Corporation Proposes Final Cash Dividend for the Year 2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.12 in 2Q 2020)

Shanghai Phichem Material Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on 31 May 2021

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.10 in 1Q 2020)

Shanghai Phichem Material Co., Ltd. Proposes Cash Dividend for the Year 2020

Shanghai Phichem Material Co., Ltd., Annual General Meeting, Apr 07, 2021

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.50 in FY 2019)

Shanghai Phichem Material Co., Ltd. to Report Fiscal Year 2020 Results on Mar 18, 2021

Investor sentiment deteriorated over the past week

New 90-day low: CN¥16.20

New 90-day low: CN¥17.90

Shanghai Phichem Material Co., Ltd. announced that it expects to receive CNY 825 million in funding

Price target lowered to CN¥23.21

New 90-day low: CN¥18.08

Third quarter earnings released

New 90-day low - CN¥20.50

Earnings released

Shanghai Phichem Material Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Scoprire le aziende sane